1. Home
  2. ICUI vs KAI Comparison

ICUI vs KAI Comparison

Compare ICUI & KAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • KAI
  • Stock Information
  • Founded
  • ICUI 1984
  • KAI 1991
  • Country
  • ICUI United States
  • KAI United States
  • Employees
  • ICUI N/A
  • KAI N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • KAI Industrial Machinery/Components
  • Sector
  • ICUI Health Care
  • KAI Industrials
  • Exchange
  • ICUI Nasdaq
  • KAI Nasdaq
  • Market Cap
  • ICUI 3.8B
  • KAI 4.4B
  • IPO Year
  • ICUI 1992
  • KAI N/A
  • Fundamental
  • Price
  • ICUI $141.97
  • KAI $376.35
  • Analyst Decision
  • ICUI Buy
  • KAI Buy
  • Analyst Count
  • ICUI 4
  • KAI 2
  • Target Price
  • ICUI $199.67
  • KAI $355.00
  • AVG Volume (30 Days)
  • ICUI 237.9K
  • KAI 278.8K
  • Earning Date
  • ICUI 05-06-2025
  • KAI 04-29-2025
  • Dividend Yield
  • ICUI N/A
  • KAI 0.36%
  • EPS Growth
  • ICUI N/A
  • KAI N/A
  • EPS
  • ICUI N/A
  • KAI 9.48
  • Revenue
  • ICUI $2,382,046,000.00
  • KAI $1,053,384,000.00
  • Revenue This Year
  • ICUI N/A
  • KAI $3.29
  • Revenue Next Year
  • ICUI $3.00
  • KAI $4.23
  • P/E Ratio
  • ICUI N/A
  • KAI $39.68
  • Revenue Growth
  • ICUI 5.44
  • KAI 9.99
  • 52 Week Low
  • ICUI $93.36
  • KAI $249.51
  • 52 Week High
  • ICUI $196.26
  • KAI $429.95
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 31.62
  • KAI 51.92
  • Support Level
  • ICUI $135.77
  • KAI $358.03
  • Resistance Level
  • ICUI $145.58
  • KAI $377.63
  • Average True Range (ATR)
  • ICUI 7.07
  • KAI 11.28
  • MACD
  • ICUI -1.55
  • KAI -1.03
  • Stochastic Oscillator
  • ICUI 21.09
  • KAI 35.44

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About KAI Kadant Inc

Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.

Share on Social Networks: